This corresponds to total injection volumes of 500600mg when accounting for choline and inositol co-administration, which is why clinical protocols converge around 500mg as the standard therapeutic dose
You can, however, uncheck the cookies that you do not want us to use
Wang J, Dudman NPB, and Wilcken DEL (1993)
Gastrointestinal issues are one of the biggest problems caused by GLP-1s, with over 70 percent of users reporting nausea and vomiting after starting or increasing the dose
Typically, results can be seen after several sessions, with continuous injections recommended for sustained results
Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits